222 related articles for article (PubMed ID: 22789650)
21. Intravitreal ranibizumab for the treatment of pathological myopia associated with choroidal neovascularization in Chinese patients.
Yang X; Dai H
Chin Med J (Engl); 2014; 127(16):2906-10. PubMed ID: 25131225
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia.
Lalloum F; Souied EH; Bastuji-Garin S; Puche N; Querques G; Glacet-Bernard A; Coscas G; Soubrane G; Leveziel N
Retina; 2010 Mar; 30(3):399-406. PubMed ID: 20038864
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal injection of 2.5 mg bevacizumab for treatment of myopic choroidal neovascularization in treatment-naive cases: a 2-year follow-up.
Chen CH; Wu PC; Chen YJ; Liu YC; Kuo HK
J Ocul Pharmacol Ther; 2011 Aug; 27(4):395-400. PubMed ID: 21770740
[TBL] [Abstract][Full Text] [Related]
24. [Intravitreal ranibizumab for choroidal neovascularization secondary to pathological myopia: 12-month results].
Cornut PL; Poli M; Feldman A; El Chehab H; Swalduz B; Burillon C; Denis P
J Fr Ophtalmol; 2010 May; 33(5):327-33. PubMed ID: 20452098
[TBL] [Abstract][Full Text] [Related]
25. HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration.
Singer MA; Awh CC; Sadda S; Freeman WR; Antoszyk AN; Wong P; Tuomi L
Ophthalmology; 2012 Jun; 119(6):1175-83. PubMed ID: 22306121
[TBL] [Abstract][Full Text] [Related]
26. One-year results of a flexible regimen with ranibizumab therapy in macular degeneration: relationship with the number of injections.
Arias L; Roman I; Masuet-Aumatell C; Rubio MJ; Caminal JM; Catala J; Pujol O
Retina; 2011; 31(7):1261-7. PubMed ID: 21499194
[TBL] [Abstract][Full Text] [Related]
27. Functional recovery after intravitreal bevacizumab treatments for idiopathic choroidal neovascularization in young adults.
Wang F; Wang W; Yu S; Wang W; Lu F; Xu F; Hu W; Jiang Y; Wu Y; Wang H; Xu X; Sun X
Retina; 2012 Apr; 32(4):679-86. PubMed ID: 22105501
[TBL] [Abstract][Full Text] [Related]
28. Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a one-year prospective study.
Finger RP; Charbel Issa P; Hendig D; Scholl HP; Holz FG
Am J Ophthalmol; 2011 Oct; 152(4):695-703. PubMed ID: 21704964
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab.
Muether PS; Hermann MM; Viebahn U; Kirchhof B; Fauser S
Ophthalmology; 2012 Oct; 119(10):2082-6. PubMed ID: 22920670
[TBL] [Abstract][Full Text] [Related]
30. Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular age-related macular degeneration.
Bolz M; Simader C; Ritter M; Ahlers C; Benesch T; PrĂ¼nte C; Schmidt-Erfurth U
Br J Ophthalmol; 2010 Feb; 94(2):185-9. PubMed ID: 19692384
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal ranibizumab for naive extrafoveal choroidal neovascularization secondary to age-related macular degeneration.
Parodi MB; Iacono P; La Spina C; Iuliano L; Lo Giudice G; Introini U; Bandello F
Retina; 2014 Nov; 34(11):2167-70. PubMed ID: 24999724
[TBL] [Abstract][Full Text] [Related]
32. Choroidal neovascularisation complicating geographic atrophy in age-related macular degeneration.
Querques G; Massamba N; Coscas F; Forte R; Souied EH
Br J Ophthalmol; 2012 Dec; 96(12):1479-83. PubMed ID: 23077229
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
[TBL] [Abstract][Full Text] [Related]
34. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.
Tilleul J; Mimoun G; Querques G; Puche N; Zerbib J; Lalloum F; Srour M; Souied EH
Retina; 2016 Mar; 36(3):483-91. PubMed ID: 26355947
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of choroidal neovascularization in pathological myopia treated with intravitreal ranibizumab.
Ladaique M; Dirani A; Ambresin A
Klin Monbl Augenheilkd; 2015 Apr; 232(4):542-7. PubMed ID: 25902117
[TBL] [Abstract][Full Text] [Related]
36. Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: one-year results of a prospective study.
Ladas ID; Kotsolis AI; Ladas DS; Niskopoulou M; Georgalas I; Papakonstantinou D; Rouvas AA
Retina; 2010 Sep; 30(8):1185-9. PubMed ID: 20539257
[TBL] [Abstract][Full Text] [Related]
37. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab.
Cho HJ; Kim CG; Yoo SJ; Cho SW; Lee DW; Kim JW; Lee JH
Am J Ophthalmol; 2013 Jan; 155(1):118-126.e1. PubMed ID: 23022163
[TBL] [Abstract][Full Text] [Related]
38. One-year outcome of two different initial dosing regimens of intravitreal ranibizumab for myopic choroidal neovascularization.
Kung YH; Wu TT; Huang YH
Acta Ophthalmol; 2014 Dec; 92(8):e615-20. PubMed ID: 24924911
[TBL] [Abstract][Full Text] [Related]
39. Longer-term outcomes of a prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
Chang LK; Spaide RF; Klancnik JM; Sorenson J; Slakter JS; Freund KB; Yannuzzi LA; Tseng JJ; Klein R
Retina; 2011 May; 31(5):821-8. PubMed ID: 21317833
[TBL] [Abstract][Full Text] [Related]
40. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P
Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]